Nelarabine 250 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB25FZ1NL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,189
Award facts
- Contract value 100% obligated
- $13,188.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nelarabine 250 mg/50 mL vials with a contract ceiling value of $13,188.76. This firm fixed-price delivery order, which is not set-aside for small businesses or other designated groups, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor is based in Conshohocken, Pennsylvania, where the pharmaceutical products will be delivered, with an ultimate completion date of September 26, 2025. Nelarabine is a specialized oncology medication used primarily in the treatment of certain leukemias and lymphomas, reflecting the Defense Health System's pharmaceutical supply needs.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, holds a $999.99 billion prime IDC with DLA Troop Support Medical running through December 2026. This comprehensive pharmaceutical vehicle enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Nelarabine exemplifies the types of specialized pharmaceutical products distributed through this prime vendor contract, which positions AmerisourceBergen as a critical supplier within the Defense Health System's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FZ1NL?
SPE2DB25FZ1NL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FZ1NL worth?
The government has obligated $13,189 on SPE2DB25FZ1NL.
Is contract SPE2DB25FZ1NL an order under another contract?
Yes. SPE2DB25FZ1NL is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ1NL competed?
The extent of competition for SPE2DB25FZ1NL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award